Rethink Medical

What Rethink Medical does

Rethink Medical S.L. is a privately held Spanish medical device company founded on December 19, 2014, as a university spin-off from the University of Las Palmas de Gran Canaria. Headquartered in Las Palmas de Gran Canaria, Spain (Calle Practicante Ignacio Rodríguez S/N, Edificio Polivalente II, Campus Universitario de Tafira, CP 35017), the company is registered as a Sociedad Limitada and operates under CNAE 8690 (other human health activities). With a workforce of 1-10 employees, Rethink Medical focuses on commercializing innovative medical concepts derived from frontline nursing experience.

The company's sole core product is T-Control®, a Foley catheter with an integrated valve mechanism that enables patients and healthcare professionals to safely open and close urine flow without additional devices. The architecture supports three operational states: controlled insertion with visual confirmation and reduced uncontrolled leakage, closed drainage that preserves bladder reflex and reduces dependence on urine bags, and open urine flow when needed. T-Control® is designed to address catheter-associated urinary tract infections (CAUTIs), reduce nursing workload during insertion and management, and improve dignity and quality of life for elderly, chronic, and long-term catheterized patients. The company is pursuing ISO 13485 certification for manufacturing process and product certification.

Rethink Medical is pre-commercial and has not disclosed revenue. Its intended go-to-market is enterprise sales to healthcare institutions and hospitals through hospital procurement channels, with target customer segments comprising hospitals performing catheterization and patients requiring indwelling urinary catheters. To date, the company has been financed entirely through Spanish and European public grants and loans: a €195,000 ENISA participatory loan (2021), €849,443 from SODECAN/Fondo Canarias Financia 1 co-financed by FEDER (2022), €33,108.92 from the INVESTIGO programme (2022), and €1,564,850 from CDTI via the EIC Accelerator SME Excellence Seal of Horizon Europe (2023), totaling approximately €2.64 million. Current activity is concentrated on international clinical trials and European regulatory authorization for T-Control® commercialization.

Name

Rethink Medical

Legal name

Rethink Medical S.L.

Website

https://rethinkmedical.es

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Rethink Medical is a Spanish medical device spin-off from the University of Las Palmas de Gran Canaria developing T-Control®, a Foley catheter with an integrated valve enabling patient-controlled urine flow. The pre-commercial company targets hospitals and long-term catheterized patients, currently advancing European clinical trials and regulatory approval.

Ownership category

akta.pro rank

Product category

Urology Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement) (HLAHALAI)

akta.pro secondary industry

Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)

Keywords

• Urology medical devices
• Foley catheters
• Indwelling urinary catheters
• Catheter-associated UTI prevention
• Patient-controlled catheters

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of T-Control Foley catheters to healthcare institutions and hospitals

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Rethink Medical develops and intends to commercialize the T-Control®, a Foley urinary catheter with an integrated valve mechanism that allows long-term catheterized patients to control urine flow without a permanent drainage bag. The product is a single-use sterile Class IIa medical device aimed at reducing catheter-associated urinary tract infections (CAUTIs) and improving quality of life, and is being prepared for CE marking under EU MDR and ISO 13485 certification.

Product overview

Rethink Medical offers a single core product — the T-Control® Foley catheter. This innovative urinary catheter features a built-in valve that allows patients to control urine flow opening and closing, eliminating the need for external devices. The product is designed for patients requiring indwelling urinary catheters, healthcare professionals performing catheter insertion, and healthcare systems seeking to reduce catheter-associated infections (CAUTIs) and nursing workload.

Differentiator

Problem solved

Functional benefit

Products and services

• T-Control® Foley Catheter A single-use sterile Class IIa Foley urinary catheter with an integrated, patient-controlled valve mechanism that allows the user to open and close the catheter without a permanent urine collection bag. Targeted at long-term catheterized patients to reduce catheter-associated urinary tract infections (CAUTIs) and improve quality of life, and intended for sale to hospitals and long-term care institutions.

Quantifiable outcome

• Reduction in catheter-associated urinary tract infections (CAUTIs)
• +2 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Fundación Canaria Universitaria de Las PalmasminorStrategic or Co-development Partner · 14 July 2022Collaboration under the Diginnova program, reinforcing commitment to research promotion and digital transformation in the Canary Islands.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Market position

Strengths4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/rethinkm
• Facebookfacebook.com/rethinkmed

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rethink Medical